Review of stem-cell transplantation for myelodysplastic syndromes in older patients in the context of the Decision Memo for Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome emanating from the Centers for Medicare and M
about
Beyond hypomethylating agents failure in patients with myelodysplastic syndromesSome aspects of allogeneic stem cell transplantation in patients with myelodysplastic syndrome: advances and controversyCurrent therapy of myelodysplastic syndromesShould elderly patients with higher-risk myelodysplastic syndromes undergo allogeneic hematopoietic stem cell transplantation?A disease risk index for patients undergoing allogeneic stem cell transplantation.Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT.When is the optimal timing for allogeneic transplantation in the case of MDS patients treated with hypomethylating agents?Up-to-date tools for risk assessment before allogeneic hematopoietic cell transplantation.Safety and efficacy of azacitidine in Belgian patients with high-risk myelodysplastic syndromes, acute myeloid leukaemia, or chronic myelomonocytic leukaemia: results of a real-life, non-interventional post-marketing survey.Validation of an Algorithm to Predict the Likelihood of an 8/8 HLA-Matched Unrelated Donor at Search Initiation.Evaluation of a disease risk index for adult patients undergoing umbilical cord blood transplantation for haematological malignancies.Serotonin receptor type 1B constitutes a therapeutic target for MDS and CMML
P2860
Q26827079-41A42811-C946-496B-93BB-A5B1672B2AF6Q27010653-DD9C38BD-0933-49F7-BEB1-45D87A401FCEQ34013796-205CAB23-457E-4679-892F-4C80474B5FAFQ34013826-141AA6CD-8D16-4361-A93A-C333E1FF4B85Q36141944-7883F8D4-5521-442C-A8CB-3FFED9CC6B36Q37389675-3D93BFF1-0A8D-47A6-972A-93B3EA0B7CDDQ38132814-0D2DDB52-DBC4-41DA-A091-8AC7AA84FED4Q38858092-E346EB70-19B8-484A-86A6-649EB31571DEQ44866521-CE00EFA7-BF13-4CB9-908A-8249DB660140Q47570389-8CBADB49-3F4E-4295-9686-C069C11D3719Q48162997-F1E7A2BA-4014-4463-B91F-601F13EB1F76Q58733645-FFC2D121-5B4A-4178-B0BC-E39DB44540C4
P2860
Review of stem-cell transplantation for myelodysplastic syndromes in older patients in the context of the Decision Memo for Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome emanating from the Centers for Medicare and M
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Review of stem-cell transplant ...... the Centers for Medicare and M
@en
type
label
Review of stem-cell transplant ...... the Centers for Medicare and M
@en
prefLabel
Review of stem-cell transplant ...... the Centers for Medicare and M
@en
P2093
P2860
P356
P1476
Review of stem-cell transplant ...... the Centers for Medicare and M
@en
P2093
Corey Cutler
Daniel Weisdorf
Mary Horowitz
Sergio A Giralt
P2860
P304
P356
10.1200/JCO.2010.32.1919
P407
P577
2011-01-10T00:00:00Z